Leukon Investments
3
24M
1
0.67
1
- Stages of investment
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Chestnut Hill.
The standard case for the fund is to invest in rounds with 9 partakers. Despite the Leukon Investments, startups are often financed by RUSNANO, Polaris Partners, NanoDimension. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, OrbiMed, NanoDimension. In the next rounds fund is usually obtained by RUSNANO, Sphera Funds Management, Skolkovo Foundation.
The high activity for fund was in 2010. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Leukon Investments performs on 4 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2016. The fund is constantly included in less than 2 deals per year.
Among the most popular fund investment industries, there are Pharmaceutical, Biopharma. Among the most popular portfolio startups of the fund, we may highlight Selecta Biosciences. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.67
- Investments by industry
- Drug Discovery (3)
- Biotechnology (3)
- Pharmaceutical (3)
- Biopharma (3)
- Investments by region
-
- United States (3)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Selecta Biosciences | 05 Apr 2010 | Biotechnology, Drug Discovery, Pharmaceutical, Biopharma | Late Stage Venture | 15M | United States, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.